Regulated information
Waregem (Belgium)/Rotterdam (The Netherlands)[1], 13 May 2016
Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Fagron received the following notifications.
Notification of The Goldman Sachs Group, Inc., received on 10 May 2016
-
On 10 May 2016, Fagron received a notification that the shareholding of The Goldman Sachs Group, Inc., a parent undertaking or a controlling person, had crossed the disclosure threshold of 3% on 4 May 2016 as the result of the acquisition of voting securities or voting rights.
-
On the notification date, The Goldman Sachs Group, Inc. held a total of 1,168,652 voting rights. 536,286 voting rights were held by Goldman Sachs International, 618,975 voting rights were held by Goldman Sachs Asset Management, L.P. and 13,391 voting rights were held by Goldman Sachs Asset Management International.
-
Based on the denominator of 32,111,827 (total number of voting rights), in total The Goldman Sachs Group, Inc., held on the notification date 3.64% of the total number of voting rights.
-
The chain of controlled companies of The Goldman Sachs Group, Inc. is attached to the notification of The Goldman Sachs Group, Inc. and can be viewed on investors.fagron.com via this link.
Notification of The Goldman Sachs Group, Inc., received on 12 May 2016
-
On 12 May 2016, Fagron received a notification that the shareholding of The Goldman Sachs Group, Inc., a parent undertaking or a controlling person, had fallen below the disclosure threshold of 3% on 6 May 2016 as the result of the disposal of voting securities or voting rights.
-
The notification of The Goldman Sachs Group, Inc. can be viewed on investors.fagron.com via this link.
In the event of differences between the English translation and the Dutch original of this press release, the latter prevails.
For more information:
Constantijn van Rietschoten
Chief Marketing Officer
Tel. +31 6 53 69 15 85
constantijn.van.rietschoten@fagron.com
Fagron profile
Fagron is a scientific pharmaceutical R&D business focused on optimising and innovating personalised pharmaceutical care. Fagron provides Fagron Specialty Pharma Services, Fagron Trademarks and Fagron Essentials to pharmacies, clinics and hospitals in 32 countries worldwide.
The Belgian company Fagron NV is located in Waregem and is listed on Euronext Brussels and Euronext Amsterdam. The operational activities of Fagron are driven by the Dutch company Fagron BV. The head office of Fagron BV is located in Rotterdam.
[1] This press release was sent out by Fagron NV and Fagron BV.
Please open the link below for the press release: